Prof. Dr. Jerzy Adamski

Accelerating Translational Research: New Research Unit Molecular Endocrinology and Metabolism

Jerzy Adamski has been head of the newly founded Research Unit Molecular Endocrinology and Metabolism at Helmholtz Zentrum München since October 1, 2018. The independent research unit catalyzes knowledge transfer into application. 

 

Prof. Dr. Jerzy Adamski. Source: Helmholtz Zentrum München

The aim of Professor Jerzy Adamski’s research activities is to specifically target and combat  major common diseases. He is motivated by the desire to develop novel, personalized diagnostic approaches and treatments. As research professor at Technische Universität München (TUM), he is often asked by students why it takes so long to channel discoveries made in the lab into clinical applications – a problem Adamski is aware of and is addressing in the Research Unit Molecular Endocrinology and Metabolism (MEM).

Previously, the research areas Molecular Endocrinology and Functional Metabolomics, together with the Genome Analysis Center under Adamski's direction, were part of the Institute of Experimental Genetics (IEG). The fact that these have now been merged in an independent research unit has, above all, simplified logistics. "Over the past eight years, we have gained crucial new insights in the field of lipodomics and developed analytical procedures. These are available to the scientists of Helmholtz Zentrum München via the Core Facility Genome Analysis Center as well as worldwide. The connection to the IEG was always very helpful," Adamski said.

The biochemist wants to identify characteristic biological features that are crucial for the development or expression of major common diseases such as diabetes, cancer or Alzheimer's. "These biomarkers are the tool for personalized medicine," said Adamski. As head of the new research unit, he can now drive these projects forward: "We can respond quickly to new insights and thus efficiently contribute to the development of new diagnoses and therapies.“

The 18-member team is currently exploring the importance of certain receptors and enzymes during signal transduction and how the signaling molecules are synthesized. "Together with the Core Facility Genome Analysis Center,“ Adamski said, “we have the expertise and state-of-the-art platforms such as genotyping, DNA sequencing, transcriptomics, and metabolomics to accurately characterize the signal transduction chain.”

Video: Genome Analysis Center

Here is a video of Vimeo. With the activation of the iframe, a connection to Vimeo is built and, if necessary, cookies are also used by Vimeo. For further information, click here.

Video: Core Facility Metabolomics

Here is a video of Vimeo. With the activation of the iframe, a connection to Vimeo is built and, if necessary, cookies are also used by Vimeo. For further information, click here.

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.